Cargando…

‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’

MicroRNAs markedly affect the immune system, and have a relevant role in CVD and autoimmune diseases. Yet, no study has analyzed their involvement in atherothrombosis related to APS and SLE patients. This study intended to: 1) identify and characterize microRNAs linked to CVD in APS and SLE; 2) asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Sánchez, C., Aguirre, M. A., Ruiz-Limón, P., Barbarroja, N., Jiménez-Gómez, Y., de la Rosa, I. Arias, Rodriguez-Ariza, A., Collantes-Estévez, E., Segui, P., Velasco, F., Cuadrado, M. J., Teruel, R., González-Conejero, R., Martínez, C., López-Pedrera, Ch.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977549/ https://www.ncbi.nlm.nih.gov/pubmed/27502756 http://dx.doi.org/10.1038/srep31375

Ejemplares similares

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches
por: Lopez-Pedrera, Chary, et al.
Publicado: (2019)

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches
por: López-Pedrera, Chary, et al.
Publicado: (2010)

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome
por: Pérez-Sánchez, Carlos, et al.
Publicado: (2018)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Expression of DDX11 and DNM1L at the 12p11 Locus Modulates Systemic Lupus Erythematosus Susceptibility
por: Saeed, Mohammad, et al.
Publicado: (2021)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022)

Decreased binding of annexin V to endothelial cells: a novel mechanism of atherothrombosis in patients with systemic lupus erythematosus
por: Cederholm, A, et al.
Publicado: (2005)

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion
por: Pérez‐Sánchez, Carlos, et al.
Publicado: (2019)

The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians
por: Franco, Juan-Sebastian, et al.
Publicado: (2014)

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα
por: Castro-Villegas, Carmen, et al.
Publicado: (2015)

Coexistence of pituitary macroadenoma with systemic lupus erythematosus and antiphospholipid syndrome
por: Valizadeh, Neda, et al.
Publicado: (2012)

Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Wirestam, Lina, et al.
Publicado: (2019)

Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Reshetnyak, Tatiana, et al.
Publicado: (2023)

Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
por: Barber, Megan R.W., et al.
Publicado: (2022)

Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome
por: Hamdani, Muhammad Afzal, et al.
Publicado: (2015)

Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hashimoto, Ritsuo, et al.
Publicado: (2018)

Tumid lupus erythematosus–like pseudovasculitic lesions in catastrophic antiphospholipid syndrome
por: Wang, Jenny Z., et al.
Publicado: (2019)

Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
por: Hisada, Ryo, et al.
Publicado: (2023)

Systemic lupus erythematosus with antiphospholipid syndrome: Cardiovascular magnetic resonance for evaluation of cardiac hypertrophy
por: Mavrogeni, Sophie I., et al.
Publicado: (2017)

Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
por: Barbarroja, Nuria, et al.
Publicado: (2022)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome.
por: Smyth, A. E., et al.
Publicado: (1996)

Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome
por: Mohammadi Kebar, Yousef, et al.
Publicado: (2019)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
por: Monzón Manzano, Elena, et al.
Publicado: (2020)

Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
por: Baños, Núria, et al.
Publicado: (2022)

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
por: Lopez-Pedrera, Chary, et al.
Publicado: (2020)

Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hajialilo, Mehrzad, et al.
Publicado: (2012)

Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Gerosa, Maria, et al.
Publicado: (2016)

Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome
por: Wind, Merlijn, et al.
Publicado: (2021)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023)

Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
por: Suzuki, Eiji, et al.
Publicado: (2023)

The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Reshetnyak, Tatiana, et al.
Publicado: (2023)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

Childhood-Onset Systemic Lupus Erythematosus Presenting With Concomitant Gastrointestinal Manifestation and Antiphospholipid Syndrome
por: Mohd Shukri, Nur Diyana, et al.
Publicado: (2023)

Bilateral Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus with Secondary Antiphospholipid Syndrome
por: Aldhefeery, Nora, et al.
Publicado: (2023)

Cell Stress Proteins in Atherothrombosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2012)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Platelet-Derived Exosomes and Atherothrombosis
por: Wei, Kangkang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gfhr2ij6pls9r2e8660vl4q257